Skip to main content

Our publications

Missing ALT text.

Scientific articles (2010-2017)

Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
Dahlgren C, Geary L, Hasselström J, Rehnberg C, Schenck-Gustafsson K, Wändell P, et al
BMJ Open 2017 Sep;7(9):e015723

Clinic continuity of care, clinical outcomes and direct costs for COPD in Sweden: a population based cohort study.
Sveréus S, Larsson K, Rehnberg C
Eur Clin Respir J 2017 ;4(1):1290193

The relationship between non-communicable disease occurrence and poverty-evidence from demographic surveillance in Matlab, Bangladesh.
Mirelman AJ, Rose S, Khan JA, Ahmed S, Peters DH, Niessen LW, et al
Health Policy Plan 2016 Jul;31(6):785-92

Willingness-to-Pay for Community-Based Health Insurance among Informal Workers in Urban Bangladesh.
Ahmed S, Hoque ME, Sarker AR, Sultana M, Islam Z, Gazi R, et al
PLoS ONE 2016 ;11(2):e0148211

Decomposing the productivity differences between hospitals in the Nordic countries.
Kittelsen SA, Winsnes BA, Anthun KS, Goude, F, Hope Ø, Häkkinen U, Kalseth B, Kilsmark J, Medin E, Rehnberg C & Rättö H (2015).
Journal of Productivity Analysis. Vol. 43(3), s 281- 293.

A Window on Geographic Variation in Health Care: Insights from EuroHOPE.
Heijink R, Engelfriet P, Rehnberg C, Kittelsen SA, Häkkinen U,
Health Econ 2015 Dec;24 Suppl 2():164-77

Costs and Quality at the Hospital Level in the Nordic Countries.
Kittelsen SA, Anthun KS, Goude F, Huitfeldt IM, Häkkinen U, Kruse M, et al
Health Econ 2015 Dec;24 Suppl 2():140-63

Outcome, Use of Resources and Their Relationship in the Treatment of AMI, Stroke and Hip Fracture at European Hospitals.
Häkkinen U, Rosenqvist G, Iversen T, Rehnberg C, Seppälä TT,
Health Econ 2015 Dec;24 Suppl 2():116-39

Towards Explaining International Differences in Health Care Performance: Results of the EuroHOPE Project.
Häkkinen U, Iversen T, Peltola M, Rehnberg C, Seppälä TT,
Health Econ 2015 Dec;24 Suppl 2():1-4

European Regional Differences in All-Cause Mortality and Length of Stay for Patients with Hip Fracture.
Medin E, Goude F, Melberg HO, Tediosi F, Belicza E, Peltola M, et al
Health Econ 2015 Dec;24 Suppl 2():53-64

Comparing ischaemic stroke in six European countries. The EuroHOPE register study.
Malmivaara A, Meretoja A, Peltola M, Numerato D, Heijink R, Engelfriet P, et al
Eur. J. Neurol. 2015 Feb;22(2):284-91, e25-6

Jumping to the wrong conclusions? An investigation of the mechanisms of reasoning errors in delusions.
Jolley S, Thompson C, Hurley J, Medin E, Butler L, Bebbington P, et al
Psychiatry Res 2014 Oct;219(2):275-82

Evaluating an early intervention in psychosis service for 'high-risk' adolescents: symptomatic and social recovery outcomes.
Lower R, Wilson J, Medin E, Corlett E, Turner R, Wheeler K, et al
Early Interv Psychiatry 2015 Jun;9(3):260-7

Acute Myocardial Infarction, Use of Percutaneous Coronary Intervention, and Mortality: A Comparative Effectiveness Analysis Covering Seven European Countries.
Hagen TP, Häkkinen U, Belicza E, Fatore G, Goude F,
Health Econ 2015 Dec;24 Suppl 2():88-101

Individual and Regional-level Factors Contributing to Variation in Length of Stay After Cerebral Infarction in Six European Countries.
Peltola M, Seppälä TT, Malmivaara A, Belicza É, Numerato D, Goude F, et al
Health Econ 2015 Dec;24 Suppl 2():38-52

Variations and Determinants of Mortality and Length of Stay of Very Low Birth Weight and Very Low for Gestational Age Infants in Seven European Countries.
Fatttore G, Numerato D, Peltola M, Banks H, Graziani R, Heijink R, et al
Health Econ 2015 Dec;24 Suppl 2():65-87

Parameter Heterogeneity In Breast Cancer Cost Regressions - Evidence From Five European Countries.
Smith J, Banks H, Campbell H, Douglas A, Fletcher E, McCallum A, et al
Health Econ 2015 Dec;24 Suppl 2():23-37

Mortality and Length of Stay of Very Low Birth Weight and Very Preterm Infants: A EuroHOPE Study.
Numerato D, Fattore G, Tediosi F, Zanini R, Peltola M, Banks H, et al
PLoS ONE 2015 ;10(6):e0131685

Measuring health-related quality of life with the EQ-5D-Y instrument in children and adolescents with asthma.
Bergfors S, Åström M, Burström K, Egmar AC
Acta Paediatr. 2015 Feb;104(2):167-73

Distribution of chronic disease mortality and deterioration in household socioeconomic status in rural Bangladesh: an analysis over a 24-year period.
Khan JA, Trujillo AJ, Ahmed S, Siddiquee AT, Alam N, Mirelman AJ, et al
Int J Epidemiol 2015 Dec;44(6):1917-26

Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
Sarker AR, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, et al
Vaccine 2015 Sep;33(38):4916-21

Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden.
Giacobini M, Medin E, Ahnemark E, Russo LJ, Carlqvist P
J Atten Disord 2018 Jan;22(1):3-13

Is healthcare a 'Necessity' or 'Luxury'? an empirical evidence from public and private sector analyses of South-East Asian countries?
Khan JA, Mahumud RA
Health Econ Rev 2015 ;5():3

Patient perspectives on centralisation of low volume, highly specialised procedures in Sweden.
Svederud I, Virhage M, Medin E, Grundström J, Friberg S, Ramsberg J
Health Policy 2015 Aug;119(8):1068-75

Updated Medication Costs From A Real-Life Cost-Effectiveness Evaluation Of Budesonide/Formoterol Maintenance And Reliever Therapy In Asthma Maintenance And Reliever Therapy In Asthma.
Medin E, Safioti G, Lindqvist F, Torvinen S
Value Health 2015 Nov;18(7):A500

Coordination pays off: a comparison of two models for organizing hip fracture care, outcomes and costs.
Löfgren S, Rehnberg C, Ljunggren G, Brommels M
Int J Health Plann Manage ;30(4):426-38

Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden.
Giacobini M, Medin E, Ahnemark E, Russo LJ, Carlqvist P
J Atten Disord 2018 Jan;22(1):3-13

Income related inequalities in New Cooperative Medical Scheme: a five-year empirical study of Junan County in China.
Yuan S, Rehnberg C, Sun X, Liu X, Meng Q
Int J Equity Health 2014 May;13():38

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults.
Gyllensten H, Hakkarainen KM, Hägg S, Carlsten A, Petzold M, Rehnberg C, et al
PLoS ONE 2014 ;9(3):e92061

Cross-country comparisons of health-care costs: the case of cancer treatment in the Nordic countries.
Kalseth J, Halvorsen T, Kalseth B, Sarheim Anthun K, Peltola M, Kautiainen K, et al
Health Policy 2014 Apr;115(2-3):172-9

The impact of age and sex on healthcare expenditure of households in Bangladesh.
Sarker AR, Mahumud RA, Sultana M, Ahmed S, Ahmed W, Khan JA
Springerplus 2014 ;3():435

Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey.
Gyllensten H, Rehnberg C, Jönsson AK, Petzold M, Carlsten A, Andersson Sundell K
BMJ Open 2013 Jun;3(6):

Health care performance comparison using a disease-based approach: the EuroHOPE project.
Häkkinen U, Iversen T, Peltola M, Seppälä TT, Malmivaara A, Belicza É, et al
Health Policy 2013 Sep;112(1-2):100-9

International hospital productivity comparison: experiences from the Nordic countries.
Medin E, Häkkinen U, Linna M, Anthun KS, Kittelsen SA, Rehnberg C, et al
Health Policy 2013 Sep;112(1-2):80-7

Productivity differences in Nordic hospitals: Can we learn from Finland?
Rehnberg C. & Häkkinen U.
Nordic Economic Policy review, No.2, 2012.

Lifetime productivity losses associated with obesity status in early adulthood: a population-based study of Swedish men.
Neovius K, Rehnberg C, Rasmussen F, Neovius M
Appl Health Econ Health Policy 2012 Sep;10(5):309-17

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'.
Gyllensten H, Hakkarainen KM, Jönsson AK, Andersson Sundell K, Hägg S, Rehnberg C, et al
Int J Clin Pharm 2012 Aug;34(4):538-46

How are the costs of drug-related morbidity measured?: a systematic literature review.
Gyllensten H, Jönsson AK, Rehnberg C, Carlsten A
Drug Saf 2012 Mar;35(3):207-19

Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis.
Medin E, Anthun KS, Häkkinen U, Kittelsen SA, Linna M, Magnussen J, et al
Eur J Health Econ 2011 Dec;12(6):509-19

Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China.
Liang X, Jin C, Wang L, Wei L, Tomson G, Rehnberg C, et al
Int J Clin Pharm 2011 Oct;33(5):750-4

Provider performance in treating poor patients--factors influencing prescribing practices in lao PDR: a cross-sectional study.
Syhakhang L, Soukaloun D, Tomson G, Petzold M, Rehnberg C, Wahlström R
BMC Health Serv Res 2011 Jan;11():3

Measuring cost efficiency in the Nordic hospitals--a cross-sectional comparison of public hospitals in 2002.
Linna M, Häkkinen U, Peltola M, Magnussen J, Anthun KS, Kittelsen S, et al
Health Care Manag Sci 2010 Dec;13(4):346-57

Calculation of costs of pregnancy- and puerperium-related care: experience from a hospital in a low-income country.
Sarowar MG, Medin E, Gazi R, Koehlmoos TP, Rehnberg C, Saifi R, et al
J Health Popul Nutr 2010 Jun;28(3):264-72

Regional variation and adherence to guidelines for drug treatment of asthma.
Arnlind MH, Wettermark B, Nokela M, Hjemdahl P, Rehnberg C, Jonsson EW
Eur. J. Clin. Pharmacol. 2010 Feb;66(2):187-98

The economic burden of psychiatric disorders in Sweden.
Tiainen A, Rehnberg C
Int J Soc Psychiatry 2010 Sep;56(5):515-26


  • Gyllensten H. Economic impact of drug-related morbidity in Sweden – Estimated using experts’ opinion, medical records and self-reports. University of Gothenburg MAY 2014, co-supervisor: Clas Rehnberg.
  • Yuan S. Quality and Expenditures of Medical Care and their Associations under NCMS: A Study in Junan of Shandong Province. Shandong University, MAY 2013, co-supervisor: Clas Rehnberg.
  • Neovius K. Work absenteeism and productivity losses associated with overweight. Social Medicine/FHV, Karolinska Institutet APR 2012, co-supervisor: Clas Rehnberg.
  • Tiainen A. Cost analysis and policy implications in psychiatric care. MMC/LIME, Karolinska Institutet, APR, 2009, main supervisor: Clas Rehnberg.
  • Arnlind Heibert M. Asthma treatment in primary care : Studies of variability and health economic aspects. MMC/LIME, Karolinska Institutet, JUN, 2009, co-supervisor: Clas Rehnberg.
  • Johansson P. Economic evaluation of public health programmes : Constraints and opportunities. Social Medicine/FHV, Karolinska Institutet, FEB., 2009, main supervisor: Clas Rehnberg.
  • Xiaojie S. Social capital and health. Shandong University, JUN, 2008, co-supervisor: Clas Rehnberg.
  • Lidgren M. Health economics of breast cancer. MMC/LIME, Karolinska Institutet, JUN 2007, main supervisor: Clas Rehnberg.
  • Sobocki P. Health Economics of Depression. MMC/LIME, Karolinska Institutet, OCT 2006, main supervisor: Clas Rehnberg. Appointed to research fellow (docent) at Karolinska Institutet in AUG 2010.
  • Borgström F. Health Economics of Osteoporosis. MMC/LIME, Karolinska Institutet, MAY 2006, main supervisor: Clas Rehnberg.
  • Meng Q. Health Care Pricing and Payment Reforms in China: The Implications for Health Service Delivery and Cost Containment. IHCAR/FHV, Karolinska Institutet, FEB 2006, main supervisor: Clas Rehnberg.
  • Lundkvist J. The role of economic evaluations in health care decision making. MMC/LIME, Karolinska Institutet, SEP, 2005, main supervisor: Clas Rehnberg. Appointed to research fellow (docent) at Karolinska Institutet in MAY 2009.
  • Masiye F. Economic Efficiency in Health Care in a Low-Income Country: Empirical Approaches and Policy Relevance. Dep. of Public Health, University of Cape Town, JUN 2005, main supervisor: Clas Rehnberg.